Laura Lynne Stockton

Array ( [id] => 6049159 [patent_doc_number] => 20020169329 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-14 [patent_title] => 'Ester Compounds, methods of controlling a pest and uses of the ester compounds' [patent_app_type] => new [patent_app_number] => 10/077901 [patent_app_country] => US [patent_app_date] => 2002-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9708 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0169/20020169329.pdf [firstpage_image] =>[orig_patent_app_number] => 10077901 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6696752 [patent_doc_number] => 20030108946 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-12 [patent_title] => 'Indolinone combinatorial libraries and related products and methods for the treatment of disease' [patent_app_type] => new [patent_app_number] => 10/076621 [patent_app_country] => US [patent_app_date] => 2002-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 43 [patent_no_of_words] => 54204 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0108/20030108946.pdf [firstpage_image] =>[orig_patent_app_number] => 10076621 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6736116 [patent_doc_number] => 20030013751 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-16 [patent_title] => 'Bis-sulfonamide hydroxyethyl-amino retroviral protease inhibitors' [patent_app_type] => new [patent_app_number] => 10/076607 [patent_app_country] => US [patent_app_date] => 2002-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28588 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0013/20030013751.pdf [firstpage_image] =>[orig_patent_app_number] => 10076607 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5988145 [patent_doc_number] => 20020099222 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-25 [patent_title] => 'Heterocyclically substituted benzoylguanidines, process for their preparation, their use as medicaments or diagnostics, and medicaments comprising them' [patent_app_type] => new [patent_app_number] => 10/075394 [patent_app_country] => US [patent_app_date] => 2002-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4213 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20020099222.pdf [firstpage_image] =>[orig_patent_app_number] => 10075394 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 174025 [patent_doc_number] => 07659404 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-02-09 [patent_title] => 'Broad spectrum 2-(substituted-amino)-benzothiazole sulfonamide HIV protease inhibitors' [patent_app_type] => utility [patent_app_number] => 10/467609 [patent_app_country] => US [patent_app_date] => 2002-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21630 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/659/07659404.pdf [firstpage_image] =>[orig_patent_app_number] => 10467609 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6439311 [patent_doc_number] => 20020128233 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-12 [patent_title] => 'Interheteroaryl 7-oxabicyclic [2.2.1]heptane oxazoles as prostaglandin F2alpha antagonists' [patent_app_type] => new [patent_app_number] => 10/071449 [patent_app_country] => US [patent_app_date] => 2002-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6246 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20020128233.pdf [firstpage_image] =>[orig_patent_app_number] => 10071449 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 711620 [patent_doc_number] => 07057040 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-06-06 [patent_title] => 'Substituted aryl alkenoic acid heterocyclic amides' [patent_app_type] => utility [patent_app_number] => 10/067546 [patent_app_country] => US [patent_app_date] => 2002-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4241 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/057/07057040.pdf [firstpage_image] =>[orig_patent_app_number] => 10067546 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1359572 [patent_doc_number] => 06573219 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-06-03 [patent_title] => 'Substituted heterocyclyl-2H-chromenes' [patent_app_type] => B1 [patent_app_number] => 10/049189 [patent_app_country] => US [patent_app_date] => 2002-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6583 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/573/06573219.pdf [firstpage_image] =>[orig_patent_app_number] => 10049189 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6774713 [patent_doc_number] => 20030018051 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-23 [patent_title] => 'Pyrazole derivatives - p38 MAP kinase inhibitors' [patent_app_type] => new [patent_app_number] => 10/066040 [patent_app_country] => US [patent_app_date] => 2002-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20336 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20030018051.pdf [firstpage_image] =>[orig_patent_app_number] => 10066040 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7386929 [patent_doc_number] => 20040082626 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-29 [patent_title] => 'Cyclic compounds exhibiting thrombopoietin receptor agonism' [patent_app_type] => new [patent_app_number] => 10/470002 [patent_app_country] => US [patent_app_date] => 2003-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37752 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20040082626.pdf [firstpage_image] =>[orig_patent_app_number] => 10470002 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6132079 [patent_doc_number] => 20020077484 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-20 [patent_title] => 'Process' [patent_app_type] => new [patent_app_number] => 10/052550 [patent_app_country] => US [patent_app_date] => 2002-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3608 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20020077484.pdf [firstpage_image] =>[orig_patent_app_number] => 10052550 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6178147 [patent_doc_number] => 20020156113 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-24 [patent_title] => ' Cycloheptene compounds' [patent_app_type] => new [patent_app_number] => 10/050666 [patent_app_country] => US [patent_app_date] => 2002-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10998 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0156/20020156113.pdf [firstpage_image] =>[orig_patent_app_number] => 10050666 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5923455 [patent_doc_number] => 20020115707 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-22 [patent_title] => 'Process for preparing pure ondansetron hydrochloride dihydrate' [patent_app_type] => new [patent_app_number] => 10/045970 [patent_app_country] => US [patent_app_date] => 2002-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2585 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20020115707.pdf [firstpage_image] =>[orig_patent_app_number] => 10045970 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6178151 [patent_doc_number] => 20020156114 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-24 [patent_title] => 'Pyrazole derivatives - p38 MAP kinase inhibitors' [patent_app_type] => new [patent_app_number] => 10/045903 [patent_app_country] => US [patent_app_date] => 2002-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20473 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0156/20020156114.pdf [firstpage_image] =>[orig_patent_app_number] => 10045903 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6809582 [patent_doc_number] => 20030199521 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-23 [patent_title] => 'Compounds, methods and compositions useful for the treatment of bovine viral diarrhea virus (BVDV) infection and hepatitis C virus (HCV) infection' [patent_app_type] => new [patent_app_number] => 10/044315 [patent_app_country] => US [patent_app_date] => 2002-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 13124 [patent_no_of_claims] => 106 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0199/20030199521.pdf [firstpage_image] =>[orig_patent_app_number] => 10044315 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1177255 [patent_doc_number] => 06747159 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-06-08 [patent_title] => 'Symmetric, monofunctionalised polymethine dyes labelling reagents' [patent_app_type] => B2 [patent_app_number] => 10/038554 [patent_app_country] => US [patent_app_date] => 2002-01-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10563 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 381 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/747/06747159.pdf [firstpage_image] =>[orig_patent_app_number] => 10038554 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6654011 [patent_doc_number] => 20030009035 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-09 [patent_title] => 'Process for producing 1,3-dialkyl-2-imidazolidinone compound' [patent_app_type] => new [patent_app_number] => 10/203937 [patent_app_country] => US [patent_app_date] => 2002-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 14418 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20030009035.pdf [firstpage_image] =>[orig_patent_app_number] => 10203937 [rel_patent_id] =>[rel_patent_doc_number] =>)